This article is in the news archive.
Cognitive Enhancers: 22nd Neuropharmacology Conference
Official Satellite to the 2012 Meeting of the Society for Neuroscience
Hilton Riverside, New Orleans, LA, USA | 11-12 October 2012
Gary Lynch, University of California, Irvine, CA, USA
Conference Organizing Committee
Graham Collingridge, University of Bristol, UK
Eric Kandel, Columbia University, NY, USA
Cognitive enhancement has become a subject of considerable research and, both in neuroscience and society at large, growing controversy. This satellite meeting will survey progress in the field from attempts to facilitate the substrates of memory and cognition in animal models to clinical studies targeted at major psychiatric disorders. Attendees will accordingly have a first-hand opportunity to learn about the broad spectrum of enhancement research ranging from epigenetics through synaptic plasticity and brain networks to behavior. Individual sessions include both cutting edge work on currently marketed drugs and experiments using novel, mechanism-based compounds. The program will therefore be of interest to those interested in present and future therapeutic prospects for autism, age-related cognitive decline, addiction, and depression. It also directly addresses the possibility of enhancement in normal subjects, a contentious issue that affects much of the neuroscience community.
Papers are invited on the following conference themes:
For more information, please visit the website
For a podcast on 'New Drug Development for Cognitive Enhancement in Mental Health: Challenges and Opportunities', please click here.
Posted on 26/01/2012
Go to the news index page.